secwatch.observer — SEC 8-K summary
======================================

Issuer:     Praxis Precision Medicines, Inc. (PRAX)
CIK:        0001689548
Form:       8-K
Filed at:   2022-05-23T23:59:59+00:00
Accession:  0001689548-22-000051
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Praxis Precision Medicines elects Jill DeSimone to Board as Class I director
----------------------------------------------------------------------------

- Jill DeSimone elected to Board as Class I director effective May 23, 2022.
- Board determined DeSimone is independent under Nasdaq listing standards.
- DeSimone to receive compensation per company's Non-Employee Director Compensation Policy.
- No related person transactions or arrangements exist with DeSimone.
- DeSimone entered into standard indemnification agreement with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689548/000168954822000051/0001689548-22-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689548/000168954822000051/prax-20220521.htm
  HTML page:      https://secwatch.observer/filing/0001689548-22-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer